Rising to Defend Its Billion-Dollar Tylenol Brand, Kenvue Lures CMO from Mondelēz

Tylenol has been in the headlines for the last several weeks—though not for reasons any marketer would want. Despite a veritable mountain of clinical evidence to the contrary, on September […]

​Tylenol has been in the headlines for the last several weeks—though not for reasons any marketer would want. Despite a veritable mountain of clinical evidence to the contrary, on September  Read More